Usa Financial Portformulas Corp Biogen Inc. Transaction History

Usa Financial Portformulas Corp

$641 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$212.02 - $267.71 $7,632 - $9,637	-36 Reduced 85.71%	6 $1,000
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $1.89 Million - $2.28 Million	-8,504 Reduced 99.51%	42 $10,000
Q3 2023 Nov 27, 2023	BUY	$253.3 - $285.89 $9,625 - $10,863	38 Added 0.45%	8,546 $2.2 Million
Q2 2023 Nov 27, 2023	SELL	$275.25 - $318.06 $1.09 Million - $1.26 Million	-3,977 Reduced 31.85%	8,508 $2.42 Million
Q1 2023 Nov 27, 2023	BUY	$256.56 - $292.34 $3.2 Million - $3.64 Million	12,461 Added 51920.83%	12,485 $3.47 Million
Q3 2022 Oct 24, 2022	BUY	$194.69 - $268.46 $3,699 - $5,100	19 Added 380.0%	24 $6,000
Q1 2022 Aug 16, 2022	BUY	$193.77 - $244.14 $968 - $1,220	5 New	5 $1,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $804,992 - $1.03 Million	-3,595 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$282.99 - $369.05 $1.02 Million - $1.33 Million	3,595 New	3,595 $1.02 Million
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $6,142 - $9,246	-26 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $5,030 - $5,808	-19 Reduced 42.22%	26 $7,000
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $3 Million - $3.97 Million	-11,600 Reduced 99.61%	45 $12,000
Q1 2020 Apr 13, 2020	BUY	$268.85 - $341.04 $3.13 Million - $3.97 Million	11,645 New	11,645 $3.68 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $3.16 Million - $4.94 Million	-14,571 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $4.06 Million - $5.14 Million	14,571 New	14,571 $5.15 Million
Q1 2018 Apr 03, 2018	SELL	$260.13 - $367.91 $3.34 Million - $4.73 Million	-12,849 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $3.95 Million - $4.43 Million	12,849	12,849 $4.09 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.

Account